Immunomedics Inc (IMMU) 2.68 $IMMU Immunomedics to

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Immunomedics Inc (IMMU) 2.68 $IMMU

Immunomedics to Present at Upcoming Investor Conferences
GlobeNewswire - Wed Aug 31, 6:00AM CDT
Immunomedics, Inc. (Nasdaq:IMMU) today announced that the Company will present at three upcoming investor conferences:
IMMU: 2.68 (-0.09)

Preclinical Study on Enhancing Sacituzumab Govitecan (IMMU-132) Activity in SN-38-Resistant Cancer Cells Published
GlobeNewswire - Thu Aug 18, 6:00AM CDT
Immunomedics, Inc. (Nasdaq:IMMU) today announced that adding an inhibitor of ATP-binding cassette (ABC) transporters to sacituzumab govitecan, the Company's lead antibody-drug conjugate (ADC) for solid cancer therapy, increased the median survival of mice bearing a SN-38-resistant human gastric cancer cell line. Results from this preclinical study were published in Molecular Cancer Therapeutics.
IMMU: 2.68 (-0.09)

Immunomedics Announces Conference Call And Webcast For Fourth Quarter And Fiscal Year 2016 Financial Results
GlobeNewswire - Thu Aug 11, 6:00AM CDT
Immunomedics, Inc., (Nasdaq:IMMU) today announced that it will host a conference call and live audio webcast on Wednesday, August 17, 2016 at 5:00 p.m. Eastern Time to discuss financial results for the fourth quarter and fiscal year 2016, and review key clinical developments and future planned activities.
IMMU: 2.68 (-0.09)

DEADLINE TODAY: Khang & Khang LLP Announces Securities Class Action Lawsuit against Immunomedics Inc. and Reminds Investors with Losses to Contact the Firm
ACCESSWIRE - Mon Aug 08, 10:03AM CDT
IRVINE, CA / ACCESSWIRE / August 8, 2016 / Khang & Khang LLP (the "Firm" announces that a class action lawsuit was filed against Immunomedics Inc. ("Immunomedics" or the "Company" (NASDAQ: IMMU). Investors who purchased or otherwise acquired shares between April 20, 2016 and June 2, 2016 inclusive (the "Class Period", are encouraged to contact the Firm prior to the August 8, 2016, lead plaintiff motion deadline.
IMMU: 2.68 (-0.09)

FINAL DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Immunomedics Inc. (IMMU) and Lead Plaintiff Deadline - August 8, 2016
ACCESSWIRE - Mon Aug 08, 9:16AM CDT
NEW YORK, NY / ACCESSWIRE / August 8, 2016 / Bronstein, Gewirtz & Grossman, LLC, reminds investors of class action against of Immunomedics, Inc. ("Immunomedics" or the "Company" (NASDAQGM: IMMU). The class action has been filed in the United States District Court, District of New Jersey, on behalf of a class consisting of all persons or entities who purchased Immunomedics common stock between April 20, 2016 and June 2, 2016 inclusive (the "Class Period".
IMMU: 2.68 (-0.09)

IMMUNOMEDICS 72 HOUR DEADLINE ALERT: APPROXIMATELY 72 HOURS REMAIN; FORMER LOUISIANA ATTORNEY GENERAL AND KAHN SWICK & FOTI, LLC REMIND INVESTORS of Deadline in Class Action Lawsuit Against Immunomedics Inc. - IMMU
GlobeNewswire - Fri Aug 05, 9:07PM CDT
Kahn Swick & Foti, LLC ("KSF" and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with large financial interests that they have only until August 8, 2016 to file lead plaintiff applications in a securities class action lawsuit against Immunomedics Inc. (Nasdaq:IMMU). Investor losses must relate to purchases of the Company's securities between April 20, 2016 and June 2, 2016. This action is pending in the United States District Court for the District of New Jersey.
IMMU: 2.68 (-0.09)

APPROACHING DEADLINE: Lundin Law PC Announces Securities Class Action Lawsuit against Immunomedics Inc. and Reminds Investors with Losses to Contact the Firm
ACCESSWIRE - Thu Aug 04, 10:44AM CDT
LOS ANGELES, CA / ACCESSWIRE / August 4, 2016 / Lundin Law PC (the "Firm" announces that a class action lawsuit was filed against Immunomedics Inc. ("Immunomedics" or the "Company" (NASDAQ: IMMU) concerning possible violations of federal securities laws between April 20, 2016 and June 2, 2016 (the "Class Period". Investors who purchased or otherwise acquired shares during the Class Period should contact the Firm in advance of the August 8, 2016 lead plaintiff motion deadline.
IMMU: 2.68 (-0.09)

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Immunomedics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of August 8, 2016 - IMMU
GlobeNewswire - Wed Aug 03, 1:46PM CDT
The following statement is being issued by Levi & Korsinsky, LLP:
IMMU: 2.68 (-0.09)

DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of a Class Action against Immunomedics Inc. (IMMU) and Lead Platintiff Deadline: August 8, 2016
ACCESSWIRE - Wed Aug 03, 9:38AM CDT
NEW YORK, NY / ACCESSWIRE / August 3, 2016 / Bronstein, Gewirtz & Grossman, LLC, reminds investors of a class action against Immunomedics, Inc. ("Immunomedics" or the "Company" (NASDAQ: IMMU). The class action has been filed in the United States District Court, District of New Jersey, on behalf of a class consisting of all persons or entities who purchased Immunomedics common stock between April 20, 2016 and June 2, 2016 inclusive (the "Class Period".
IMMU: 2.68 (-0.09)

AUGUST 8, 2016 DEADLINE: Khang & Khang LLP Announces Securities Class Action Lawsuit against Immunomedics Inc. and Reminds Investors with Losses to Contact the Firm
ACCESSWIRE - Tue Aug 02, 5:24PM CDT
IRVINE, CA / ACCESSWIRE / August 2, 2016 / Khang & Khang LLP (the "Firm" announces that a class action lawsuit was filed against Immunomedics Inc. ("Immunomedics" or the "Company" (Nasdaq: IMMU). Investors who purchased or otherwise acquired shares between April 20, 2016 and June 2, 2016 inclusive (the "Class Period", are encouraged to contact the Firm prior to the August 8, 2016 lead plaintiff motion deadline.
IMMU: 2.68 (-0.09)

Rosen Law Firm Reminds Immunomedics, Inc. Investors of Important August 8 Deadline in Class Action - IMMU
GlobeNewswire - Tue Aug 02, 12:51PM CDT
Rosen Law Firm, a global investor rights law firm, reminds purchasers of Immunomedics, Inc. securities (NASDAQ:IMMU) from April 20, 2016 through June 2, 2016, both dates inclusive (the "Class Period" of the important August 8, 2016 lead plaintiff deadline in the class action. The lawsuit seeks to recover damages for Immunomedics investors under the federal securities laws.
IMMU: 2.68 (-0.09)

INVESTOR ALERT: Hagens Berman Reminds Immunomedics, Inc. (NASDAQ: IMMU) Investors of August 8, 2016 Lead Plaintiff Deadline
Marketwire Canada - Mon Aug 01, 8:30AM CDT
SAN FRANCISCO, CA--(Marketwired - August 01, 2016) - Hagens Berman Sobol Shapiro LLP, a national investor-rights law firm, reminds Immunomedics, Inc. (NASDAQ: IMMU) investors of the August 8, 2016 Lead Plaintiff deadline in the securities class action filed in the United States District Court for the District of New Jersey.
IMMU: 2.68 (-0.09)

IMPORTANT SHAREHOLDER NOTICE: Khang & Khang LLP Announces Securities Class Action Lawsuit against Immunomedics Inc. and Reminds Investors with Losses to Contact the Firm
ACCESSWIRE - Fri Jul 29, 10:11AM CDT
IRVINE, CA / ACCESSWIRE / July 29, 2016 / Khang & Khang LLP (the "Firm" announces that a class action lawsuit was filed against Immunomedics Inc. ("Immunomedics" or the "Company" (NASDAQ: IMMU). Investors who purchased or otherwise acquired shares between April 20, 2016 and June 2, 2016 inclusive (the "Class Period", are encouraged to contact the Firm prior to the August 8, 2016, lead plaintiff motion deadline.
IMMU: 2.68 (-0.09)

INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Immunomedics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of August 8, 2016
BusinessWire - Fri Jul 29, 8:35AM CDT
The following statement is being issued by Levi & Korsinsky, LLP:
IMMU: 2.68 (-0.09)

Brower Piven Alerts Shareholders of Upcoming Deadline in Class Action Lawsuit and Encourages Investors Who Have Losses in Excess of $100,000 From Investment in Immunomedics, Inc. to Contact the Firm - IMMU
GlobeNewswire - Thu Jul 28, 2:45PM CDT
The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the District of New Jersey on behalf of purchasers of Immunomedics, Inc. (Nasdaq:IMMU) ("Immunomedics" or the "Company" securities during the period between April 20, 2016 and June 3, 2016, inclusive (the "Class Period". Investors with losses in excess of $100,000 who wish to become proactively involved in the litigation have until August 8, 2016 to seek appointment as lead plaintiff.
IMMU: 2.68 (-0.09)

SHAREHOLDER ALERT: Rosen Law Firm Reminds Immunomedics, Inc. Investors of Important Deadline in Class Action - IMMU
BusinessWire - Thu Jun 23, 2:34PM CDT
Rosen Law Firm, a global investor rights law firm, reminds purchasers of Immunomedics, Inc. securities (NASDAQ:IMMU) from April 20, 2016 through June 2, 2016, both dates inclusive (the "Class Period" of the important August 8, 2016 lead plaintiff deadline in the class action. The lawsuit seeks to recover damages for Immunomedics investors under the federal securities laws.
IMMU: 2.68 (-0.09)

DEADLINE ALERT: Lundin Law PC Announces Securities Class Action Lawsuit Against Immunomedics Inc. and Reminds Investors with Losses to Contact the Firm
BusinessWire - Thu Jun 23, 4:30AM CDT
Lundin Law PC announces a class action lawsuit has been filed against Immunomedics Inc. ("Immunomedics" or the "Company" (Nasdaq: IMMU) concerning possible violations of federal securities laws between April 20, 2016 and June 3, 2016. Investors who purchased or otherwise acquired shares during the Class Period should contact the Firm in advance of the August 8, 2016, lead plaintiff motion deadline.
IMMU: 2.68 (-0.09)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Net Zero Efforts to Cost Europe €60B Annually by 2050

Updated Category News Views 91

Hefty Prices Loom Over Net Zero Commitments Well, strap in for a wallet buster, folks. Europe's largest players are staring down the barrel of a colossal €60 billion annual bill to clean up their carbon mess by 2050. That's the ticker in Senken's latest report, 'Pace of Change 2026.' Talks like these remind me there's no such thing as a free lunch, especially when...

Continue Reading
DemandTec Leads the Pack in Retail Pricing Arena

Updated Category News Views 26

DemandTec's Climb to Retail Pricing Stardom The news hitting the streets is that DemandTec's carved out a top spot in QKS Group's SPARK Matrix™ for Intelligent Retail Pricing & Promotion Optimization for 2026. In an industry filled with slick operators and gimmicks, it takes some real chops to stand out. They've clinched this position by rolling out a platform that ties...

Continue Reading
Roche Delivers Endotrophin Assay to Nordic Bioscience Lab

Updated Category News Views 43

Roche Opens New Frontier in Diagnostic Biomarkers Get ready to chew on this: Roche Diagnostics is bringing something new to Nordic Bioscience's CLIA lab. They're offering up their Endotrophin research prototype assay on the cobas® e801 Analyzer. Now, what does this mean for the scientific world? Well, it might just shake things up for those battling cardiovascular and...

Continue Reading
Phoenix Contact Achieves Guinness Record in Wiring

Updated Category News Views 160

A Blitz of Wires and Innovation Boy, did Phoenix Contact shake things up in Blomberg. On a crisp November day, a group of fresh-faced first-year students pulled off something astounding—wiring 500 terminal blocks in a jaw-dropping 2 minutes and 20 seconds. This wasn’t just any effort; it was enough to earn them a shiny new Guinness World Record. What they did wasn’t...

Continue Reading
DoGo Power Revamps Energy for Remote Indonesian Isle

Updated Category News Views 77

Bringing Light to Pagerungan Kecil Island These days, if you wander into the fishing communities of Pagerungan Kecil Island, the buzz isn't just from the daily catch. Residents are talking about power, and not the kind you get from a generator spluttering along—I'm talking about a brand-new energy storage system that’s turning the lights on in ways these folks have...

Continue Reading
Evotec’s $2.9M Grant Advances Drug Safety Tech

Updated Category News Views 101

Revitalizing Drug Development with Human Stem Cells Evotec's latest win—a crisp $2.9 million grant from the Gates Foundation—is like a shot of adrenaline for drug safety innovation. This isn't just another drop in the bucket; it's a solid boost toward improving how we screen potential drugs for fetal risks before they're tossed into the costly whirlpool of clinical...

Continue Reading
Medtronic's Bold Move to Own Carotid Market Full-Scale

Updated Category News Views 44

When a giant like Medtronic makes a move, you can bet investors take notice, and this latest acquisition is no exception. They’re reaching into their deep pockets to acquire Contego Medical, a company shaking up the world of carotid artery disease treatments. It’s a tactical strike to solidify their leadership in cardiovascular solutions. Medtronic's Bet on Innovation...

Continue Reading
ROBOTERA Debuts XHAND 1 Pro-U in NVIDIA Demo

Updated Category News Views 20

ROBOTERA Steps Up with XHAND 1 Pro-U Move over, traditional robotics; ROBOTERA is here to shake things up with their latest marvel, the XHAND 1 Pro-U. This futuristic gadget isn't just making waves at the Conference on Robot Learning (CoRL) where Jim Fan of NVIDIA spotlighted it in his GR00T 2 demo, it's setting a new bar for robotic dexterity. Hand in Glove with Human...

Continue Reading
Atomera Preps for Key Craig-Hallum Conference

Updated Category News Views 13

Unpacking the NYC Gathering Alight, let's comb through the moving parts here. Atomera Inc., ticker NASDAQ: ATOM for those eyeing the dance of numbers, is all set to step into the limelight at the 17th Annual Craig-Hallum Alpha Select Conference on November 17, 2026. This shindig isn't just another date on the calendar; it's a strategic haunt where Atomera will rub...

Continue Reading
ICCSD in Beijing: AI and Culture's Future Explored

Updated Category News Views 114

AI's Intersection with Culture in the Spotlight Imagine a room full of people hammering out the future of AI and culture—it starts to feel like a melting pot for the mind. That was the scene in Beijing when the ICCSD Advisory Committee congregated on October 26, 2026. With experts pooling from four different countries, there was no shortage of fireworks. They hashed out...

Continue Reading

Top 5 Most Recently Viewed Articles

CSX Corporation Teams Up for Q1 Earnings Conference Call

Updated Category News Views 131

CSX Corporation's Upcoming First Quarter Earnings Release CSX Corporation (NASDAQ: CSX) is excited to announce its first-quarter earnings release slated for a date following the market close. This pivotal moment will take place on a Wednesday, with management inviting participants to join their insightful conference call. Details of the Earnings Call A live webcast and...

Continue Reading
Innovative ReWalk 7 Exoskeleton Now Available for All Users

Updated Category News Views 345

The Launch of ReWalk 7 Personal Exoskeleton Lifeward Ltd., known for its groundbreaking innovations in medical technology, has recently unveiled its seventh generation of personal exoskeletons, the ReWalk 7. This next-generation device is now available throughout the United States, primarily aiming to benefit individuals with spinal cord injuries (SCI). This remarkable...

Continue Reading
Eve's Certification Progress Marks Aviation Milestone

Updated Category News Views 51

Certification: A New Lease on Air Mobility Folks, the air mobility future is taking one giant leap forward, and Eve Air Mobility is right at the helm. With Brazil’s aviation authority spearheading a consultation for updated airworthiness criteria and Eve stepping up for European certification, these advancements aren't just footnotes—they're headlines. NYSE:EVEX has...

Continue Reading
Exciting Launch of Lofthill Residences: A Premier Investment Hub

Updated Category News Views 164

Lofthill Residences: A Fresh Investment Opportunity in Kuala Lumpur The real estate market in Kuala Lumpur has taken an exciting turn with the introduction of Lofthill Residences, a groundbreaking initiative by TRE Towers and the Armani Group. Conveniently located near the vibrant KLCC and just a short walk from the Raja Uda MRT station, this development stands out as a...

Continue Reading
Exclaimer Welcomes Rob Singer as CEO to Propel Growth

Updated Category News Views 385

Exclaimer Welcomes New Leadership for Future Growth Exclaimer, a leader in email signature management, has announced the appointment of Rob Singer as its new CEO. This comes at a key moment for the company, which has recently doubled its annual revenue and is set to expand its presence with new offices opening soon. Experience and Vision Matter Rob Singer comes to...

Continue Reading